Utama › Leukemia Limfositik Kronik › Maine
Kajian klinikal Leukemia Limfositik Kronik di Maine
6 kajian untuk Leukemia Limfositik Kronik sedang mencari peserta di lokasi di Maine.
Bandar di Maine
Teks kajian rasmi (Bahasa Inggeris)
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
- MaineHealth Maine Medical Center - Portland, Portland
- MaineHealth Cancer Care and IV Therapy - South Portland, South Portland
Mengambil pesertaFasa 3
Umur 65 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07321652Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Harold Alfond Center for Cancer Care, Augusta
- MaineHealth Waldo Hospital, Belfast
- Lafayette Family Cancer Center-EMMC, Brewer
- dan 9 lagi
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
- Study Site 105, Westbrook
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07582432Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
- Harold Alfond Center for Cancer Care, Augusta
- MaineHealth Cancer Care and IV Therapy - Brunswick, Brunswick
- Mid Coast Hospital, Brunswick
- dan 4 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT04269902Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia
- New England Cancer Specialists, Scarborough
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Jan 2026 · NCT06333262Zanubrutinib and Venetoclax in CLL (ZANU-VEN)
- New England Cancer Specialists, Scarborough
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Dis 2025 · NCT05168930Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.